Urologic Imaging

Which Imaging Study Is Best for Renovascular Hypertension with Severe Renal Dysfunction?

·
Which Imaging Study Is Best for Renovascular Hypertension with Severe Renal Dysfunction?

A 68-year-old male with resistant hypertension presents for follow-up. His blood pressure remains elevated despite a four-drug regimen, and his latest labs reveal a progressive decline in renal function, with an estimated Glomerular Filtration Rate (eGFR) now at 25 mL/min/1.73 m2. You have a high index of suspicion for renovascular hypertension as the underlying cause, but the patient’s severe renal impairment makes the choice of imaging study critical. Ordering a test that requires contrast could potentially worsen his kidney function. This article provides a clinical workflow for this specific scenario, guiding you to the most appropriate initial imaging study. Based on the American College of Radiology (ACR) Appropriateness Criteria, the recommended first step is a study rated as “Usually Appropriate”: US duplex Doppler of the retroperitoneal kidneys.

Who Fits This Clinical Scenario?

This guidance is specifically for patients where there is a high clinical suspicion for renovascular hypertension (RVH) in the setting of significantly decreased renal function. The key inclusion criteria are:

  • High Index of Suspicion: This is not a screening scenario. It applies to patients with clinical features suggestive of RVH, such as resistant hypertension (uncontrolled on ≥3 medications), a significant rise in serum creatinine after starting an ACE inhibitor or ARB, unexplained renal atrophy or size discrepancy between kidneys, or new-onset severe hypertension in older adults.
  • Decreased Renal Function: The patient has an estimated Glomerular Filtration Rate (eGFR) of less than 30 mL/min/1.73 m2. This specific threshold is critical because it significantly alters the risk-benefit profile of imaging modalities that use intravenous contrast agents.

This workflow does not apply to patients with a similar suspicion for RVH but normal or only mildly impaired renal function. For those individuals, the risk associated with contrast-enhanced studies is lower, and the imaging options may differ. If your patient has a high suspicion for RVH but an eGFR >30 mL/min/1.73 m2, a different diagnostic pathway is recommended.

What Diagnoses Are You Working Up in This Scenario?

When ordering imaging for this presentation, you are primarily investigating for a treatable cause of hypertension and renal decline. The differential diagnosis is centered on vascular pathology affecting the kidneys.

Renal Artery Stenosis (RAS) is the principal diagnosis under consideration. This narrowing of one or both renal arteries reduces blood flow to the kidney, activating the renin-angiotensin-aldosterone system and causing severe hypertension. In this patient demographic (older adult with likely vascular risk factors), the most common cause is atherosclerosis. A less common but important cause, particularly in younger women, is fibromuscular dysplasia (FMD), a non-inflammatory, non-atherosclerotic vascular disease.

Intrinsic Chronic Kidney Disease (CKD) is also a key consideration. The patient’s severe renal dysfunction may be the primary problem, with hypertension being a consequence rather than the cause. The imaging study helps assess for structural causes of CKD (like polycystic kidney disease or signs of chronic pyelonephritis) and can evaluate kidney size and parenchymal thickness, which provide prognostic information.

Other Renal Vascular Pathologies, while less common, may be incidentally discovered or considered. These include renal artery aneurysms, dissections, or arteriovenous fistulas. While not the primary target of the workup, their identification is clinically significant and can be detected by the recommended imaging.

Why Is US Duplex Doppler of the Kidneys the Recommended Study for This Presentation?

For a patient with a high suspicion of renovascular hypertension and an eGFR below 30 mL/min/1.73 m2, the ACR designates US duplex Doppler kidneys retroperitoneal as “Usually Appropriate.” This recommendation is driven primarily by safety and diagnostic capability in this high-risk population.

The primary advantage of renal Doppler ultrasound is its safety profile. It uses no ionizing radiation (0 mSv) and, crucially, does not require any intravenous contrast media. This completely avoids the risk of contrast-induced nephropathy (CIN) from iodinated contrast and nephrogenic systemic fibrosis (NSF) from gadolinium-based contrast agents—both of which are significant concerns in patients with severe renal impairment.

From a diagnostic standpoint, duplex Doppler is a powerful tool. It combines standard B-mode ultrasound to visualize the kidney’s structure and size with Doppler ultrasound to directly assess blood flow. A skilled sonographer can measure peak systolic velocities (PSV) and calculate the renal-aortic ratio (RAR) to identify hemodynamically significant stenosis. It can also assess downstream effects, such as tardus-parvus waveforms in the intrarenal arteries, which indicate flow-limiting upstream disease.

Alternative studies are rated lower for compelling reasons in this specific scenario:

  • MRA abdomen without and with IV contrast is rated “Usually not appropriate.” The risk of NSF from gadolinium-based contrast agents is highest in patients with an eGFR <30, making this a high-risk choice. While a non-contrast MRA is an option, its diagnostic accuracy for RAS is lower than other modalities.
  • CTA abdomen with IV contrast is rated “May be appropriate.” While CTA offers excellent anatomic detail of the renal arteries, the use of iodinated contrast carries a substantial risk of precipitating a further, potentially irreversible, decline in renal function. It is generally reserved for cases where ultrasound is non-diagnostic and the clinical need is very high.
  • ACE-inhibitor renography is rated “Usually not appropriate” because its diagnostic accuracy is significantly diminished in patients with poor baseline renal function (eGFR <30), leading to a high rate of false-negative or indeterminate results.

What’s Next After US Duplex Doppler? Downstream Workflow

The results of the renal Doppler ultrasound will guide your subsequent management decisions. The workflow typically branches into three paths.

If the study is positive for significant renal artery stenosis: A finding of a peak systolic velocity >200 cm/s or a renal-aortic ratio >3.5 suggests a hemodynamically significant stenosis. The next step is a referral to a specialist, typically an interventional radiologist, interventional nephrologist, or vascular surgeon. They will evaluate the patient for potential revascularization with angioplasty and/or stenting. This decision is complex and weighs the potential benefits of improved blood pressure control and preserved renal function against the procedural risks.

If the study is negative: A technically adequate study that shows no evidence of stenosis makes hemodynamically significant renovascular disease much less likely. The clinical focus should then shift to managing the patient’s hypertension and chronic kidney disease medically. This involves optimizing antihypertensive therapy and addressing other potential causes of CKD. Further vascular imaging is generally not indicated.

If the study is indeterminate or technically limited: This is a common challenge, often due to overlying bowel gas or the patient’s body habitus. If the sonographer cannot adequately visualize the entire main renal artery, the report will be inconclusive. In this situation, if your clinical suspicion remains high, another non-invasive study is warranted. MRA abdomen without IV contrast is also rated “Usually Appropriate” and can be an excellent next step to visualize the vessel anatomy without contrast risk. If that is also non-diagnostic, a carefully considered CTA (rated “May be appropriate”) may be pursued after a thorough discussion of the risks of contrast-induced nephropathy with the patient and consultation with radiology and nephrology.

Pitfalls to Avoid (and When to Get Help)

Navigating this clinical scenario requires careful attention to detail to avoid common missteps that can impact patient safety and diagnostic accuracy.

  • Ordering Contrast Without Checking Labs: The most critical pitfall is ordering a CTA or contrast-enhanced MRA without being aware of the patient’s severely reduced eGFR. Always verify recent renal function before ordering any contrast-based imaging.
  • Accepting a “Technically Limited” Study as Negative: If the ultrasound report indicates suboptimal visualization of the renal artery origins, do not interpret this as a normal study. This is an indeterminate result that requires a next step if clinical suspicion is high.
  • Ignoring the Possibility of Fibromuscular Dysplasia (FMD): While atherosclerosis is more common in older patients, remember FMD as a cause of RAS, especially in younger patients (e.g., women under 50). The classic “string of beads” appearance may be seen on imaging.

If the non-invasive imaging is inconclusive and your clinical suspicion for a correctable lesion remains strong, this is the time to escalate. A multidisciplinary discussion involving nephrology, radiology, and potentially vascular surgery or interventional radiology is essential to weigh the risks and benefits of proceeding to more invasive or higher-risk diagnostics like CTA or digital subtraction angiography.

Related ACR Topics and Tools

For a comprehensive overview of imaging for all clinical variants of this condition, please see our parent topic hub article. For further exploration of adjacent scenarios or imaging techniques, the following GigHz resources are available.

Frequently Asked Questions

Why is MRA with contrast ‘Usually Not Appropriate’ for a patient with an eGFR under 30?

For patients with an eGFR below 30 mL/min/1.73 m2, the use of gadolinium-based contrast agents (GBCAs) carries a significant risk of nephrogenic systemic fibrosis (NSF). NSF is a rare but severe and potentially fatal fibrosing disease affecting the skin, joints, and internal organs. Because of this risk, MRA with contrast is generally avoided in this population unless the potential benefits are deemed to far outweigh the risks.

If the renal Doppler ultrasound is negative, can I confidently rule out renovascular hypertension?

A technically adequate and well-performed renal Doppler ultrasound has a high negative predictive value. If the study clearly visualizes the renal arteries and shows no evidence of significant stenosis, it is highly unlikely that the patient has hemodynamically significant renovascular disease. In this case, the clinical focus should shift to other causes of hypertension and chronic kidney disease.

What makes a renal Doppler ultrasound ‘technically limited’?

Several factors can limit the quality of a renal Doppler exam. The most common are the patient’s body habitus (obesity can make it difficult for sound waves to penetrate to the kidneys) and overlying bowel gas, which can obscure the view of the renal arteries, particularly at their origin from the aorta. If the sonographer cannot obtain clear images and Doppler signals from the entire length of the main renal arteries, the study is considered technically limited or indeterminate.

Is a non-contrast MRA a good alternative to ultrasound in this scenario?

Yes, MRA of the abdomen without IV contrast is also rated as ‘Usually Appropriate’ by the ACR for this specific scenario. It can be an excellent alternative or a follow-up test if the ultrasound is technically limited. Non-contrast MRA techniques, such as time-of-flight imaging, can visualize the anatomy of the renal arteries without the risks associated with gadolinium. However, it may be less effective at determining the hemodynamic significance of a stenosis compared to Doppler ultrasound.

If my patient’s eGFR improves to above 30 after medical management, does this imaging recommendation change?

Yes, it would. The ACR Appropriateness Criteria are highly dependent on the specific clinical parameters at the time of decision-making. If the patient’s eGFR improves to over 30 mL/min/1.73 m2, they would fit a different clinical scenario (‘High index of suspicion of renovascular hypertension. Normal renal function.’). In that case, the risk-benefit analysis for contrast-enhanced studies like CTA and MRA changes, and they become more appropriate options.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026